SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond.

Publication Title

Lancet Diabetes Endocrinol

Authors

Katherine Tuttle, Providence Medical Research Center, Providence Health Care, Spokane, WA 99204, USAFollow

Document Type

Article

Publication Date

1-1-2021

Keywords

Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus; Glucosides; Humans; Kidney; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2

Area of Special Interest

Kidney & Diabetes

Specialty/Research Institute

Endocrinology